Company Filing History:
Years Active: 2025
Title: JungHun Lee: Innovator in Hemoglobin Derivatives
Introduction
JungHun Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical innovations, particularly in the development of blood substitutes.
Latest Patents
One of JungHun Lee's key inventions is a hemoglobin derivative co-conjugated with fatty acid-linked polyethylene glycol (FA-PEG) and alkoxy polyethylene glycol (alkoxy-PEG). This invention relates to a method for creating a hemoglobin derivative that exhibits non-toxicity and extended intravascular retention time. The patent highlights various embodiments, including crosslinked hemoglobin that is co-conjugated with both FA-PEG and alkoxy-PEG derivatives. JungHun Lee holds 1 patent for this innovative work.
Career Highlights
Throughout his career, JungHun Lee has worked with prominent companies such as Sun Bio, Inc. and Samsung Display Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biomedical research and development.
Collaborations
JungHun Lee has collaborated with talented individuals, including Kwang Nho and Minjung Ahn. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
JungHun Lee's work in developing hemoglobin derivatives represents a significant advancement in blood substitute technology. His innovative approach and collaborations have the potential to impact the medical field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.